Oxygen-ozone therapy in the treatment of adipose tissue diseases

Submitted: 5 September 2016
Accepted: 5 September 2016
Published: 20 September 2016
Abstract Views: 8330
PDF: 2797
HTML: 6349
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


The panniculosis or edematous fibrosclerotic panniculopathy (PEFS), commonly called cellulite is a subcutaneous adipose disease that afflicts the vast majority of women at all ages. PEFS is framed as a subcutaneous adipose suffering from venous and lymphatic stasis whose etiology is multifactorial. Many others are the implications and clinical relapses of diseases of inflammatory or autoimmune basis that determine disease states with involvement of the patient’s general conditions. The oxygen-ozone therapy, thanks to its abilities of improving the rheological properties of the microcirculation, immuno-modulating and anti-inflammatory abnormalities, arises as adjuvant and is a valid method, which is also an alternative compared to conventional protocols.

Cuccio, G., & Franzini, M. (2016). Oxygen-ozone therapy in the treatment of adipose tissue diseases. Ozone Therapy, 1(2), 25–33. https://doi.org/10.4081/ozone.2016.6270


Download data is not yet available.